Effect of lipo-chitooligosaccharide on early growth of C4 grass seedlings.

J Exp Bot

Divisions of Plant Science and Biochemistry University of Missouri, Columbia, MO 65211, USA Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA

Published: September 2015

Although lipo-chitooligosaccharides (LCOs) are important signal molecules for plant-symbiont interactions, a number of reports suggest that LCOs can directly impact plant growth and development, separate from any role in plant symbioses. In order to investigate this more closely, maize and Setaria seedlings were treated with LCO and their growth was evaluated. The data indicate that LCO treatment significantly enhanced root growth. RNA-seq transcriptomic analysis of LCO-treated maize roots identified a number of genes whose expression was significantly affected by the treatment. Among these genes, some LCO-up-regulated genes are likely involved in root growth promotion. Interestingly, some stress-related genes were down-regulated after LCO treatment, which might indicate reallocation of resources from defense responses to plant growth. The promoter activity of several LCO-up-regulated genes using a β-glucuronidase reporter system was further analysed. The results showed that the promoters were activated by LCO treatment. The data indicate that LCO can directly impact maize root growth and gene expression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566972PMC
http://dx.doi.org/10.1093/jxb/erv260DOI Listing

Publication Analysis

Top Keywords

lco treatment
12
root growth
12
directly impact
8
plant growth
8
data indicate
8
indicate lco
8
lco-up-regulated genes
8
growth
7
lco
5
genes
5

Similar Publications

Battery technology has attained a key position as an energy storage technology in decarbonization of energy systems. Lithium-ion batteries have become the dominant technology currently used in consumer appliances, electric vehicles (EVs), and industrial applications. However, lithium-ion batteries are not alike and can have different cathode chemistries which makes their recycling more complex.

View Article and Find Full Text PDF

The degree of exercise-induced oxygen desaturation and outcomes following antifibrotic drug therapy in asymptomatic patients with fibrosing interstitial lung disease (FILD) remain unclear. We compared clinical data, incidence of annual FILD progression, overall survival, and tolerability after initiating nintedanib between 58 patients with dyspnea and 18 patients without. Annual FILD progression was defined as >10% decrease in forced vital capacity (FVC), >15% decrease in diffusing capacity of the lungs for carbon monoxide (D), developing acute exacerbations, or FILD-related death within 1 year of starting nintedanib.

View Article and Find Full Text PDF
Article Synopsis
  • - The study explored the risk factors and consequences of acute exacerbations in patients with progressive fibrosing interstitial lung diseases (ILDs), using data from the INBUILD trial, which involved treatments with nintedanib versus placebo.
  • - Results showed that 8.7% of patients experienced acute exacerbations, with lower lung function and older age being significant risk factors, while nintedanib treatment seemed to reduce the risk of these events.
  • - The analysis indicated that acute exacerbations are linked to high mortality rates, with approximately 19% of patients at risk of death within 30 days following such events.
View Article and Find Full Text PDF

Recently, it has been hypothesized that alpha-synuclein protein strain morphology may be associated with clinical subtypes of alpha-synucleinopathies, like Parkinson's disease and multiple system atrophy. However, direct evidence is lacking due to the caveat of conformation-specific characterization of protein strain morphology. Here we present a new cell model based in vitro method to explore various alpha-synuclein (αsyn) aggregate morphotypes.

View Article and Find Full Text PDF

Autologous transplantation of P63 lung progenitor cells in patients with bronchiectasis: A randomized, single-blind, controlled trial.

Cell Rep Med

November 2024

Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai 200025, China. Electronic address:

Non-cystic fibrosis bronchiectasis is a progressive respiratory disease with limited treatment options, prompting the exploration of regenerative therapies. This study investigates the safety and efficacy of autologous P63 progenitor cell transplantation in a randomized, single-blind, controlled, phase 1/2 trial. Thirty-seven patients receive bronchoscopic airway clearance (B-ACT) (n = 19) or B-ACT plus P63 progenitor cells (n = 18).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!